FG director granted 722 shares; holdings rise to 47,728

F&G Annuities & Life, Inc. (FG) director Douglas K. Ammerman acquired 722 shares of unrestricted common stock on 10/01/2025 as payment in lieu of cash director fees.

Rhea-AI Filing Summary

F&G Annuities & Life, Inc. (FG) director Douglas K. Ammerman acquired 722 shares of unrestricted common stock on 10/01/2025 as payment in lieu of cash director fees. After the grant, Mr. Ammerman beneficially owns 47,728 shares. The Form 4 was signed on 10/03/2025 by an attorney-in-fact. The filing lists the acquisition as a non-derivative transaction coded A(1) and shows a transaction price of $0, reflecting a fee-for-equity award rather than a market purchase.

Insights

Corporate Governance Analyst

Director received equity in lieu of cash fees: 722 shares on 10/01/2025.

Receiving unrestricted common stock instead of cash is a common board compensation practice that aligns director incentives with shareholder outcomes. The filing indicates the award was non-derivative and issued at $0, which denotes a fee conversion rather than a purchase.

This change increases the director's direct stake to 47,728 shares, modestly raising his ownership and potential alignment with shareholders; the Form 4 provides a clear, single transaction item and no dispositions.

Insider Trade Summary

Grant/Award: 722 shares

Grant/Award 1 txn

Insider Ammerman Douglas K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	722	$0.00	$0.00

Holdings After Transaction: Common Stock — 47,728 shares (Direct)

Footnotes (1)

1. F1. Grant of unrestricted common stock in lieu of cash director fees.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did FG director Douglas K. Ammerman report on Form 4?

He reported receipt of 722 unrestricted common shares on 10/01/2025 as payment in lieu of cash director fees.

How many FG shares does Douglas K. Ammerman own after the transaction?

Following the reported grant, he beneficially owns 47,728 shares.

What was the reported price for the shares on the Form 4?

The transaction shows a price of $0, indicating the shares were issued as compensation rather than purchased.

When was the Form 4 signed and filed for this transaction?

The Form 4 includes a signature dated 10/03/2025, and the transaction date is 10/01/2025.

Was this a purchase or a compensation issuance?

The filing labels the transaction as non-derivative with code A(1) and a price of $0, indicating a compensation issuance (grant) in lieu of cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 10:05 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Ammerman Douglas K

(Last) (First) (Middle)

801 GRAND AVENUE

SUITE 2600

(Street)

DES MOINES IA 50309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
F&G Annuities & Life, Inc. [ FG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A(1)		722	A	$0	47,728	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of unrestricted common stock in lieu of cash director fees.

	/s/ Tessa Cantonwine, attorney-in-fact	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.